Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases.
Gardell JL, Maurer ME, Childs MM, Pham MN, Meengs B, Julien SH, Tan C, Boster DR, Quach P, Therriault JH, Hermansky G, Patton DT, Bowser J, Chen A, Morgan NN, Gilbertson EA, Bogatzki L, Encarnacion K, McMahan CJ, Crane CA, Swiderek KM. Gardell JL, et al. Among authors: bogatzki l. Front Immunol. 2024 Nov 4;15:1452537. doi: 10.3389/fimmu.2024.1452537. eCollection 2024. Front Immunol. 2024. PMID: 39559361 Free PMC article.
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation.
Skeeters S, Bagale K, Stepanyuk G, Thieker D, Aguhob A, Chan KK, Dutzar B, Shalygin S, Shajahan A, Yang X, DaRosa PA, Frazier E, Sauer MM, Bogatzki L, Byrnes-Blake KA, Song Y, Azadi P, Tarcha E, Zhang L, Procko E. Skeeters S, et al. Among authors: bogatzki l. Mol Ther Methods Clin Dev. 2024 Jul 19;32(3):101301. doi: 10.1016/j.omtm.2024.101301. eCollection 2024 Sep 12. Mol Ther Methods Clin Dev. 2024. PMID: 39185275 Free PMC article.
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies.
Lee J, Geiss GK, Demirkan G, Vellano CP, Filanoski B, Lu Y, Ju Z, Yu S, Guo H, Bogatzki LY, Carter W, Meredith RK, Krishnamurthy S, Ding Z, Beechem JM, Mills GB. Lee J, et al. Among authors: bogatzki ly. Mol Cell Proteomics. 2018 Jun;17(6):1245-1258. doi: 10.1074/mcp.RA117.000291. Epub 2018 Mar 12. Mol Cell Proteomics. 2018. PMID: 29531020 Free PMC article.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis.
Llanos-Cuentas A, Calderón W, Cruz M, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Bertholet S, Laughlin EM, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Piazza FM. Llanos-Cuentas A, et al. Among authors: bogatzki ly. Vaccine. 2010 Oct 28;28(46):7427-35. doi: 10.1016/j.vaccine.2010.08.092. Epub 2010 Sep 17. Vaccine. 2010. PMID: 20851080 Clinical Trial.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.
Nascimento E, Fernandes DF, Vieira EP, Campos-Neto A, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Pine SO, Cowgill KD, Reed SG, Piazza FM. Nascimento E, et al. Among authors: bogatzki ly. Vaccine. 2010 Sep 14;28(40):6581-7. doi: 10.1016/j.vaccine.2010.07.063. Epub 2010 Aug 3. Vaccine. 2010. PMID: 20688040 Clinical Trial.
16 results